Zorayr Manukyan

Spinal Muscular Atrophy (SMA) is a genetic disorder characterized by the loss of motor neurons in the spinal cord and lower brain stem, resulting in severe and progressive muscular atrophy and weakness. The disorder has different types, distinguished by the age of onset and severity of symptoms, and is a leading genetic cause of infant death worldwide. As one of the forefronts of medical research, SMA research has been advancing rapidly over the last few years. Breakthroughs in genetics, cellular biology, and therapeutic treatments have improved our understanding of the disease and offered promising pathways towards potential cures. One of the unsung heroes behind these advancements, often hidden behind the curtain of laboratory work, is statistics.  The role of statistics in advancing medical research is as vital as it is diverse. From experimental design to data analysis, statistical models are critical for uncovering patterns in complex data, predicting disease progression, and ass